Related Experiment Video
Updated: Jun 12, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
[Arresting effect of p16 and dll4 transfection on cell cycle of K562 cells]
Jie-Fang Shen1, Hong-Bing Rui, Jin-Zi Su
1Department of Rheumatology and Hematology, The First Hospital Affiliated to Fujian Medical University, Fuzhou 350004, Fujian Province, China.
Abstract:
This study was purposed to investigate the expression and role of eukaryotic expression vector containing p16, dll4 genes in leukemia K562 cells. A vector pBudCE4.1-16-dll4 containing wild type p16cDNA and dll4cDNA was designed and constructed, then this vector was transfected into leukemia K562 cells by using lipofectamine 2000. The expression of p16 and dll4 genes was detected by Western blot, the cell growth curve and cell cycle were determined by CCK-8 kit and flow cytometry respectively. The results showed that the recombinant plasmid pBudCE4.1-16-dll4 was constructed and transfected into K562 cells in vitro successfully. The expression of exogenous P16 and Dll4 proteins could be detected in K562 cells. After transfection for 48 hours, the K562 cells were arrested in G(1) phase, the cell count increased in G(0)/G(1) phase and reduced in S phase, the cell proliferation decreased as compared with control. It is concluded that the p16 and dll4 genes can simultaneously express in K562 cells transfected with recombinant plasmid pBudCE4.1-16-dll4 in vitro which results in G(0)/G(1) arrest and reduces cell proliferation.
Insights
Introducing p16 and delta-like 4 (Dll4) genes into leukemia K562 cells via a recombinant plasmid effectively inhibited cell proliferation. This genetic modification resulted in cell cycle arrest at the G0/G1 phase, offering a potential therapeutic strategy for leukemia.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Context:
- Leukemia K562 cells are a common model for studying chronic myeloid leukemia.
- Understanding the role of specific genes in leukemia cell proliferation is crucial for developing targeted therapies.
- Eukaryotic expression vectors are essential tools for investigating gene function in vitro.
Purpose:
- To investigate the simultaneous expression and functional role of p16 and DLL4 genes in leukemia K562 cells.
- To construct and validate a novel eukaryotic expression vector (pBudCE4.1-16-dll4) for co-expressing p16 and DLL4.
- To assess the impact of p16 and DLL4 co-expression on K562 cell proliferation and cell cycle progression.
Summary:
- A recombinant plasmid, pBudCE4.1-16-dll4, was successfully constructed and transfected into K562 cells, leading to detectable expression of exogenous P16 and Dll4 proteins.
- Transfection with the pBudCE4.1-16-dll4 vector induced significant G(0)/G(1) phase arrest in K562 cells.
- The co-expression of p16 and DLL4 genes resulted in a marked reduction in K562 cell proliferation compared to control groups.
Impact:
- Demonstrates the feasibility of simultaneous p16 and DLL4 gene expression in leukemia cells using a eukaryotic vector.
- Provides evidence for the anti-proliferative effects of p16 and DLL4 co-expression, specifically G(0)/G(1) arrest, in K562 cells.
- Highlights a potential therapeutic strategy for leukemia by targeting cell cycle regulation through combined p16 and DLL4 gene delivery.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

